BG Medicine (OTCMKTS:BGMD) Shares Cross Above 200-Day Moving Average – Should You Sell?

Shares of BG Medicine Inc. (OTCMKTS:BGMD) crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.00 and traded as high as $0.0001. BG Medicine shares last traded at $0.0001, with a volume of 1,834 shares trading hands.

BG Medicine Stock Performance

BG Medicine Company Profile

BG Medicine, Inc, headquartered in Waltham, Massachusetts, is a clinical diagnostics company specializing in proprietary biomarker assays for the diagnosis and management of cardiovascular and renal diseases. The company’s flagship product is a B-type natriuretic peptide (BNP) test, offered both as a laboratory-developed test in its CLIA-certified facility and as reagent kits compatible with major immunoassay analyzers. This test aids clinicians in assessing heart failure severity and guiding patient treatment decisions.

Founded in the early 2000s, BG Medicine has established partnerships with hospital and reference laboratories across North America and select international markets.